SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001753926-23-000827
Filing Date
2023-06-21
Accepted
2023-06-21 16:56:16
Documents
1
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3770
  Complete submission text file 0001753926-23-000827.txt   5162
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC (Issuer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST., SUITE 505 PITTSBURGH PA 15208
Business Address
Chancellor Michael B (Reporting) CIK: 0001959360 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41575 | Film No.: 231030595